No, the All-Star vote is not a referendum on Biogenesis-connected players - MLB

The first batch of voting results for the All-Star game will be out today. And as Bob Nightengale notes, there are a lot of players who, based on performance, should be All-Star candidates but who may not get much support. Specifically, the Biogenesis-connected players like Ryan Braun, Melky Cabrera and Nelson Cruz. All of whom are having great years, but all of whom served PED suspensions last year.

Each of them had different circumstances involving their use of performance-enhancing drugs. All served suspensions. They apologized. And, soon, we will all find out whether they’ll truly be forgiven . . . Considering the All-Star Game is a showcase for the fans, who determine the starting lineup, perhaps this will be a barometer for whether fans are softening their stance toward PEDs.

Eh, no. Because that implies that fans have ever considered performance on the field n the first half of the season as the be-all, end-all of All-Star Game worthiness. Maybe the fan vote has hewed closer to rewarding worthy first-half players in recent years, but there are still a plethora of reasons fans will or will not vote for a guy. A lot of it is totally disconnected from performance and has more to do with how often the team reminds fans to vote, how strong the ballpark’s cell phone reception is and what kind of attendance the team had in mid-April when MLB starts pushing All-Star voting for some damn reason.

More fundamentally — and this may blow your mind — fans often vote for stars when they vote for All-Stars. Derek Jeter will likely be the starting AL shortstop. This is not because of his performance. It’s not because fans will be punishing Alexi Ramirez for some sort of transgression the rest of us have missed. It’s because he’s Derek Jeter and Derek Jeter is a big star and he’s famous and Alexi Ramirez ain’t. Which is fine, because it’s a fan vote and they can vote for any reason they want to. Often times, being famous or compelling or playing for a popular team matters a hell of a lot more than anything.

Ryan Braun had always been famous and popular before the PED stuff, so sure, I imagine if suddenly becomes an All-Star also-ran it’s in large part because of his now-sullied reputation. Jhonny Perlata could get a surge of support because he now plays for the Cardinals, not because fans have suddenly softened their stance on PEDs. Guys like Melky Cabrera and Nelson Cruz might get soft support because of the drugs or it could be just as much a function of them being Melky Cabrera and Nelson Cruz. Which, in terms of star power puts them a lot closer to Alexi Ramirez than it does Derek Jeter.

Poring over All-Star voting is fun to some, but mostly pointless. Trying to draw definitive conclusions about any specific fan opinion from them, however, is a fool’s errand.

ARLINGTON, Texas — The Texas Rangers signed Jacob deGrom to a $185 million, five-year deal in free agency last winter hoping the two-time NL Cy Young Award winner could help them get back to the playoffs for the first time since 2016 and make a push toward winning a World Series.

They also knew the risks, with the pitcher coming off two injury-plagued seasons with the New York Mets.

Even with deGrom sidelined since late April, the AL West-leading Rangers are off to the best start in franchise history – but now will be without their prized acquisition until at least next year. The team said Tuesday that deGrom will have season-ending surgery next week to repair a torn ulnar collateral ligament in his right elbow.

“We’ve got a special group here and to not be able to be out there and help them win, that stinks,” deGrom said, pausing several times with tears in his eyes. “Wanting to be out there and helping the team, it’s a disappointment.”

General manager Chris Young said Tuesday the decision on surgery came after an MRI on deGrom’s ailing right elbow, but the extent of what is required might not be determined until the operation is performed next week.

Tommy John surgery, in which the damaged ligament is replaced, is often needed to fix a torn UCL, but Young and the Rangers didn’t go as far as saying the pitcher would have that particular procedure. After being drafted by the New York Mets in 2010, deGrom made six starts in the minors that summer before needing Tommy John surgery and missing all of 2011, three years before his big league debut.

DeGrom last pitched April 28 against the New York Yankees, when he exited early because of injury concerns for the second time in a span of three starts. The announcement about surgery came a day after deGrom was transferred to the 60-day injured list.

Young said the latest MRI showed more inflammation and significant structural damage in the ligament that wasn’t there on the scan after deGrom left the game against the Yankees.

“The results of that MRI show that we have not made progress. And in fact, we’ve identified some damage to the ligament,” Young said. “It’s obviously a tough blow for Jacob, for certainly the Rangers. But we do feel this is what is right for Jacob in his career. We’re confident he’ll make a full recovery.”

Young and deGrom, who turns 35 later this month, said the goal is for the pitcher to return near the end of next season. Both said they were glad to have clarity on what was wrong with the elbow.

Texas won all six games started by deGrom (2-0), but the right-hander threw only 30 1/3 innings. He has a 2.67 ERA with 45 strikeouts and four walks. He threw 3 2/3 scoreless innings against the Yankees in his last start before leaving because of discomfort in his arm.

The Rangers went into Tuesday night’s game against St. Louis with a 39-20 record, the first time they were 19 games over .500 since the end of 2016, their last winning season.

Before going home to Florida over the weekend for the birth of his third child, deGrom threw his fifth bullpen last Wednesday in Detroit.

“I’d have days where I’d feel really good, days where I didn’t feel great. So I was kind of riding a roller coaster there for a little bit,” deGrom said. “They said originally there, we just saw some inflammation. … Getting an MRI right after you pitch, I feel like anybody would have inflammation. So, you know, I was hoping that that would get out of there and I would be fine. But it just didn’t work out that way.”

DeGrom spent his first nine big league seasons with the Mets, but was limited by injuries to 156 1/3 innings over 26 starts during his last two years in New York.

He had a career-low 1.08 ERA over 92 innings in 2021 before missing the final three months of the season with right forearm tightness and a sprained elbow.

The four-time All-Star didn’t make his first big league start last year until Aug. 2 after being shut down late in spring training because of a stress reaction in his right scapula.

His latest injury almost surely will trigger Texas’ conditional option on deGrom’s contract for 2028.

The option takes effect if deGrom has Tommy John surgery on his right elbow from 2023-26 or has any right elbow or shoulder injury that causes him to be on the IL for any period of 130 consecutive days during any season or 186 days in a row during any service period.

The conditional option would be for $20 million, $30 million or $37 million, depending on deGrom’s performance during the contract and health following the 2027 season.

“I feel bad for Jake. If I know Jake, he’ll have the surgery and come back and finish his career strong,” second-year Mets manager Buck Showalter said. “I know how much it means to him. He enjoys pitching. It’s certainly sad news for all of us.”